Overall, these observations strongly suggest that EphB6 increases drug sensitivity by suppressing Akt signaling in doxorubicin-treated T-ALL cells, which ultimately enhances the apoptotic response. Here, AKT1 is linked to acute lymphoblastic leukemia.